Table 2. Postoperative functional outcomes.
| Characteristic | Preop. (n=3,000) | Postop. 2 weeks (n=2,997) | Postop. 3 months (n=2,199) | Postop. 6 months (n=1,853) | p-valuea | |
|---|---|---|---|---|---|---|
| IPSS | ||||||
| IPSS, storage symptom score | 7.9±3.4 | 6.9±3.3 | 5.0±2.9 | 3.9±2.6 | 0.001 | |
| IPSS, voiding symptom score | 11.4±5.2 | 4.8±4.8 | 2.9±3.6 | 2.7±3.6 | 0.001 | |
| IPSS, total score | 19.3±7.7 | 11.7±7.1 | 7.9±5.9 | 6.6±5.8 | 0.001 | |
| IPSS, QoL score | 3.9±1.1 | 2.5±1.6 | 1.8±1.4 | 1.4±1.3 | 0.001 | |
| OABSS | 6.3±3.4 | 6.5±3.5 | 4.7±3.2 | 3.3±2.5 | 0.002 | |
| Qmax (mL/s) | 9.4±4.8 | - | 21.8±11.6 | 22.2±11.3 | 0.003 | |
| Post-void residual volume (mL) | 51.0 (20.0–109.0) | - | 6.0 (0.0–31.5) | 2.0 (0.0–27.0) | 0.001 | |
Values are presented as mean±standard deviation or median (interquartile range).
Preop., preoperative; Postop., postoperative; IPSS, International Prostate Symptom Score; QoL, quality of life; OABSS, Overactive Bladder Symptom Score; Qmax, maximum flow rate.
a:p-values represent the comparison between the preoperative and 6-month postoperative results.